Thursday, 21 March 2019

Biogen, Eisai scrap Alzheimer drug trials

Biogen Inc and Eisai Co Ltd said on Thursday they will discontinue two late-stage trials testing an experimental treatment for Alzheimer's disease.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)